Hiroshi Gyotoku

6PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsEmergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 29, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.

Fumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto

|Aug 14, 2023
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study).

Yusuke Okuma, Shogo Nomura, Kiichiro Ninomiya

|Feb 22, 2023
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.

Rei Noguchi, Akihiro Yoshimura, Junji Uchino

|Sep 23, 2022
Evaluation of a Triage Checklist for Mild COVID-19 Outpatients in Predicting Subsequent Emergency Department Visits and Hospitalization during the Isolation Period: A Single-Center Retrospective Study.

Yasuhiro Tanaka, Kazuko Yamamoto, Shimpei Morimoto

|Jul 13, 2021
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis.

Shinnosuke Takemoto, Kazumasa Akagi, Sawana Ono

|Nov 20, 2020
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutation.

Yosuke Dotsu, Minoru Fukuda, Noritaka Honda

Pageof 1

Frequent Collaborators

3 joint publications

Minoru Fukuda

2 joint publications

Shinnosuke Takemoto

2 joint publications

Hirokazu Taniguchi

1 joint publications

Hiroyuki Yamaguchi